Related Experiment Video
Updated: Jun 20, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Child Neurology: Dravet syndrome: when to suspect the diagnosis
John J Millichap1, Sookyong Koh, Linda C Laux
1Division of Neurology, Children's Memorial Hospital, Northwestern University Medical School, Chicago, IL 60614, USA. jmillichap@childrensmemorial.org
Insights
Dravet syndrome (DS), a severe epilepsy, begins with prolonged seizures in infancy, often mistaken for febrile seizures. Early diagnosis via SCN1A genetic testing is crucial for management and improved outcomes.
Area of Science:
- Neurology
- Genetics
- Pediatric Epilepsy
Background:
- Dravet syndrome (DS), formerly severe myoclonic epilepsy in infancy (SMEI), is a severe epileptic encephalopathy.
- It manifests with prolonged seizures in the first year of life, often triggered by fever and misdiagnosed as febrile seizures.
Observation:
- Initial EEGs and neuroimaging are typically normal in DS.
- Developmental delay and regression appear in the second year, accompanied by severe seizure types like status epilepticus and myoclonic seizures.
Findings:
- Diagnosis is confirmed through genetic testing, identifying mutations in the SCN1A gene.
- Delayed diagnosis is common due to initial presentation mimicking febrile seizures.
Implications:
- Early recognition and diagnosis of DS are critical.
- Appropriate anticonvulsant management and treatment plans can reduce seizure frequency and severity.
- Timely intervention may improve long-term developmental outcomes for children with Dravet syndrome.
Abstract:
Dravet syndrome (DS), previously known as severe myoclonic epilepsy in infancy (SMEI), is an epileptic encephalopathy that presents with prolonged seizures in the first year of life. The seizures often occur with fever or illness, and are frequently initially categorized as febrile seizures. The correct diagnosis of DS and appropriate follow-up are typically delayed. The EEG is normal at onset, and neuroimaging reveals no structural lesion. Early development is normal, but signs of regression appear in the second year of life and are often accompanied by convulsive status epilepticus, alternating hemiconvulsions, and myoclonic seizures. Diagnosis can be confirmed by genetic testing that is now available, and shows mutations within the SCN1A gene. Early recognition and diagnosis of DS and management with appropriate anticonvulsants and treatment plan may reduce the seizure burden and improve long-term developmental outcome.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction
Seizures ll: Types
Encephalitis l: Introduction

